Bioage Labs To Participate In TD Cowen's 45Th Annual Health Care Conference
TD Cowen's 45th Annual health care conference is taking place on March 3–5, 2025, at the Boston Marriott Copley Place in Boston, MA. The conference incorporates presentations, fireside chats and ...
pharmaphorum5d
Ex-Jazz, Sunesis exec Swisher takes over at NodThera
another preclinical study of the drug found that NT-0796 and another NLRP3 inhibitor codenamed NT-0249 were as effective at inducing weight loss in obese mice as Novo Nordisk’s GLP-1 agonist ...
pharmaphorum6d
BioAge's $100m IPO, and other biotech financings
The company is focusing on the development of oral apelin receptor (APJ) agonist azelaprag ... of the drug and hopes to take a brain-penetrant NLRP3 inhibitor for neuroinflammatory diseases ...
FierceBiotech6d
Fierce Biotech Fundraising Tracker '25: Bambusa banks $90M; Newleos emerges with $93M
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...